Table 2. Illustration of included BP_ND data (±s.d.) from the largest cluster in each t-map.

	MIST 1–MIST control cluster	MIST 2–MIST control cluster	MIST 2–MIST 1 cluster
d-Amphetamine subgroup
BPND
MIST control	1.5±0.64	2.18±0.39	2.44±0.47
MIST 1	1.28±0.57	2.09±0.42	2.43±0.42
MIST 2	1.33±0.78	1.92±0.45	2.21±0.45
Delta BPND
MIST 1–MIST control	−14.95±14.24	−4.18±9.28	0.49±11.36
MIST 2–MIST control	−15.37±28.53	−10.1±20.85	−7.27±22.49
MIST 2–MIST 1	−0.82±31.82	−5.72±23.17	−8±17.87
Placebo subgroup
BPND
MIST control	1.5±0.27	2.15±0.24	1.85±0.28
MIST 1	1.29±0.21	2.01±0.24	1.95±0.17
MIST 2	1.44±0.33	1.92±0.17	1.73±0.21
Delta BPND
MIST 1–MIST control	−12.53±12.62	−6.61±6.41	6.79±13.9
MIST 2–MIST control	−4.1±13.19	−10.48±6.07	−5.86±9.82
MIST 2–MIST 1	11.88±22.98	−3.78±8.71	−11.35±7.5

Abbreviations: BP_ND, non-displaceable binding potential; MIST, Montreal Imaging Stress Task.

As the clusters were identified on the basis of their significance, the BP_ND values extracted from those clusters are by definition statistically different. Those values that were used to generate the t-map are in bold.